Who’s Going to ASCO 2027
Jun 4–8, 2027 Chicago, IL ~44k attendees Website
296 exhibitors at the American Society of Clinical Oncology (ASCO) 2027 Annual Meeting, a ~44,000-person, mostly clinical meeting of oncologists, clinical researchers and oncology biopharma teams. As of Oct 8, 2026.
Speakers and other attendees will be added as ASCO 2027 gets closer.
| Organization | ASCO 2027 Attendance |
|---|---|
1Cell.Ai Cupertino, CA | |
Single-cell multi-omics testing of live circulating tumor cells from blood, with AI models that predict homologous recombination deficiency. | Booth Exhibiting at Booth 24016 |
AbbVie North Chicago, IL | |
Global drugmaker whose cancer medicines include venetoclax and ibrutinib for blood cancers and the ADC mirvetuximab soravtansine for ovarian cancer. | Booth Exhibiting at Booth 27033 |
Accord BioPharma Raleigh, NC | |
Specialty arm of the Intas group marketing the prostate cancer drug Camcevi, lenalidomide, and supportive-care biosimilars such as filgrastim and pegfilgrastim. | Booth Exhibiting at Booth 37073 |
Acrotech Biopharma East Windsor, NJ | |
Specialty drug company commercializing approved cancer medicines in the US, including treatments for T-cell lymphoma. | Booth Exhibiting at Booth 10092 |
Adaptive Biotechnologies Seattle, WA | |
Immune-sequencing company whose clonoSEQ test measures minimal residual disease in myeloma, leukemia and lymphoma. | Booth Exhibiting at Booth 17151 |
Advanced Clinical Deerfield, IL | |
Clinical development partner offering CRO, functional service provider and staffing services from early-phase research to commercialization. | Booth Exhibiting at Booth IH05 |
Advanced CTS Somerset, NJ | |
FDA-registered drug wholesaler providing clinical trial supply services: comparator sourcing, import and export, and drug depot storage. | Booth Exhibiting at Booth 35142 |
Agendia Irvine, CA | |
Breast cancer genomics company whose MammaPrint and BluePrint tests gauge recurrence risk and tumor subtype to guide early-stage treatment. | Booth Exhibiting at Booth 27147 |
Agilent Technologies Santa Clara, CA | |
Laboratory technology company whose clinical offerings include pathology staining systems, PD-L1 companion diagnostics and genomic assays for cancer testing. | Booth Exhibiting at Booth 13149 |
Aignostics Berlin, Germany | |
AI pathology company analyzing tissue images and multimodal data for biopharma, from target discovery to trials and companion diagnostics. | Booth Exhibiting at Booth IH15 |
Akeso Zhongshan City, China | |
Chinese antibody drugmaker with bispecific immunotherapies, including the PD-1/VEGF antibody ivonescimab for lung cancer. | Booth Exhibiting at Booth 37147 |
Allucent Cary, NC | |
Contract research organization running oncology and hematology trials for small and mid-size biopharma, from preclinical work to Phase IV. | Booth Exhibiting at Booth 27036 |
Almac Craigavon, UK | |
Diagnostic services unit of the Almac group, running biomarker and companion diagnostic development, multi-omic analysis and clinical testing for drug trials. | Booth Exhibiting at Booth 15157 |
ALX Oncology South San Francisco, CA | |
Clinical-stage immuno-oncology biotech developing evorpacept, a CD47 blocker, with positive data in HER2-positive gastric cancer. | Booth Exhibiting at Booth IH09 |
American Society of Hematology Washington, DC | |
Professional society of hematologists supporting research, education and advocacy on blood diseases, with meetings, journals and awards. | Booth Exhibiting at Booth 10024 |
Amgen Thousand Oaks, CA | |
Biotechnology drugmaker with cancer medicines for lung, blood and colorectal cancers, including targeted therapies and bispecific T-cell engagers. | Booth Exhibiting at Booth 22025 |
Amoy Diagnostics Xiamen, China | |
Chinese maker of PCR and sequencing kits that detect tumor gene mutations, including companion diagnostics widely used in lung cancer. | Booth Exhibiting at Booth 22114 |
AplusA Lyon, France | |
French healthcare research company that collects real-world prescribing and patient data worldwide and turns it into insights for drugmakers. | Booth Exhibiting at Booth 14156 |
Arcus Biosciences Hayward, CA | |
Clinical-stage biotech with registrational programs in kidney cancer (HIF-2α inhibitor casdatifan) and pancreatic cancer (CD73 inhibitor quemliclustat). | Booth Exhibiting at Booth 32146 |
Arima Genomics Orlando, FL | |
Genomics company whose CLIA lab tests tumors using whole-genome sequencing plus 3D genome structure; also sells research kits and software. | Booth Exhibiting at Booth 10082 |
Instantly find 20 buyers from companies at ASCO 2027
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
When and where is ASCO 2027?
ASCO Annual Meeting 2027 runs June 4–8, 2027, at McCormick Place in Chicago, IL.
Where is the ASCO 2027 floor plan?
See the organizer’s interactive exhibit hall floor plan. This guide gives each exhibitor’s booth number.
How do I register for ASCO 2027?
Fees and registration are on the organizer's registration page.
What is ASCO 2027?
The American Society of Clinical Oncology’s Annual Meeting, held June 4–8, 2027 at McCormick Place in Chicago — the largest clinical oncology meeting, with about 44,000 oncologists, clinical researchers, medical affairs and oncology biopharma teams. Its exhibit hall gathers the drugmakers with cancer medicines, oncology biotechs, diagnostics, clinical-research and health-technology companies, publishers, patient advocacy groups and professional societies.
What is in this guide?
Every organization exhibiting at ASCO 2027 so far: 296 exhibitors with their booth numbers from the public floor plan — 296 organizations in one list, each typed and tagged with up to three product areas, and a short description for 296.
Where is the program?
ASCO had not published the 2027 program when this guide was built: abstracts and sessions are released in the months before the meeting. This guide lists who is exhibiting, from the public floor plan; when the program appears, the sessions and the organizations presenting will be added here.
Where does this list come from?
The organizer’s own public exhibit floor plan and the profile each exhibitor published on it — address, website, product categories and a company description. 269 of the 296 exhibitors had published a description and 266 a list of product categories; where an exhibitor published none, the short description is condensed from its own website or states what is well established about it. Nothing here requires a login.
How are organizations typed?
By what each organization does in cancer care: drug developers (large pharma and biotech), then the diagnostics and device companies, health technology companies, clinical research organizations and other services around them — and the patient advocacy groups, professional societies, cancer centers, publishers and agencies. The focus tags — the cancers a drugmaker is known for, or what a company does, such as clinical trials, biomarkers or AI and data — are judged from each exhibitor’s own profile, at most three each. Meeting rooms some companies hold off the exhibit floor are noted, never listed as booths.
How current is it?
Pulled from the public floor plan on October 8, 2026. Exhibitors keep signing up until the meeting, so the list will grow.
Why are there no names?
This guide is about which organizations are in the room, not which people. It never publishes a person’s name.
Browse ASCO 2027 by
- Clinical trials 58
- Biomarkers and genomics 44
- AI and data 38
- Blood cancers 36
- Lung cancer 28
- Genitourinary cancers 24
- Gastrointestinal cancers 21
- Breast cancer 18
- Immunotherapy 17
- Imaging and radiation 17
- Patient support and survivorship 14
- Antibody-drug conjugates 9
- Cell and gene therapy 8
- Melanoma and skin cancers 7
- Gynecologic cancers 6
Organizations with their own page
296 organizations — every exhibitor and every organization with 1 or more presentations.
- 1Cell.Ai
- AbbVie
- Accord BioPharma
- Acrotech Biopharma
- Adaptive Biotechnologies
- Adium
- Advanced Clinical
- Advanced CTS
- Agendia
- Agilent Technologies
- Aignostics
- Akeso
- Allucent
- Almac
- ALX Oncology
- American Association for Cancer Research
- American Society of Hematology
- Amgen
- Amoy Diagnostics
- Amplity
- AplusA
- Aptitude Health
- Arcus Biosciences
- Arima Genomics
- Ascentage Pharma
- ASCO
- Association for Value-Based Cancer Care
- Association of Cancer Care Centers
- Astellas
- AstraZeneca
- AVEO Oncology
- Axiom Healthcare Strategies
- Bayer
- BeOne Medicines
- BillionToOne Northstar
- Binaytara
- Biocartis
- Biodesix
- BioNTech
- BioTouch
- Blood Cancer United
- Blue Faery
- Blue Spark Technologies
- Boehringer Ingelheim
- BostonGene
- Bradford Hill
- Bristol Myers Squibb
- Burning Rock Dx
- Caidya
- Cardinal Health
- Caris Life Sciences
- Celcuity
- Certara
- Chugai Pharmaceutical
- Cincinnati Children's Hospital
- City of Hope
- Clario
- Cleveland Clinic Cancer Institute
- CMIC Group
- Cogent Biosciences
- Cogitars
- Coherus Oncology
- College of American Pathologists
- ConcertAI
- Cooler Heads
- Corcept Therapeutics
- Creatv Bio
- Curium
- Daiichi Sankyo
- DAVA Oncology
- Decera Clinical
- Deciphera Pharmaceuticals
- Delphi Diagnostics
- Dendreon Pharmaceuticals
- DOD Congressionally Directed Medical Research Programs
- Doximity
- Dr. Reddy's Laboratories
- Early Access Care
- Einstein Hospital Israelita
- Eisai
- Elephas
- Elevar Therapeutics
- Eli Lilly
- EMD Serono (Merck KGaA)
- Emerald Clinical
- Enable Injections
- enGene
- Ergomed
- European Cancer Organisation
- Everest Clinical Research
- EVERSANA
- Exact Sciences
- Exai Bio
- Exelixis
- Fennec Pharmaceuticals
- Flatiron Health
- Fore Biotherapeutics
- Formedics
- Fortrea
- Foundation Medicine
- Fred Hutch Cancer Center
- GE HealthCare
- Genentech
- Genmab
- GenomeWeb
- Genomic Testing Cooperative
- Geron
- Gilead and Kite
- Glenmark Pharmaceuticals
- GRAIL
- GSK
- Guardant Health
- Harvest Integrated Research Organization
- Haymarket Oncology
- HealthWell Foundation
- Henlius
- Hoosier Cancer Research Network
- ICON
- IDEAYA Biosciences
- Illumina
- Imagene AI
- Imaging Endpoints
- ImmunityBio
- Immunocore
- Immunome
- Incyte
- Inhibrx Biosciences
- Inizio
- Institut Curie
- Intermountain Health
- International Association for the Study of Lung Cancer
- International Myeloma Society
- International Society of Liquid Biopsy
- International Society of Oncology Prevention and Treatments
- Invivoscribe
- Invivyd
- Iovance Biotherapeutics
- Ipsen
- IQVIA
- Japanese Society of Medical Oncology
- Jazz Pharmaceuticals
- John Theurer Cancer Center
- Johnson & Johnson
- Kapadi
- Karyopharm Therapeutics
- King Hussein Cancer Foundation and Center
- Klein Hersh
- Kognitic
- KoNECT
- Korean Society of Medical Oncology
- Kura Oncology
- La Roche-Posay
- Labcorp
- Lantheus
- Lee Health
- Legend Biotech
- Livestrong Foundation
- Lumara Bio
- Lunit
- Manifold
- Massive Bio
- McKesson
- Med Learning Group
- Medable
- Median Technologies
- Medical University of South Carolina
- Medidata
- Medlive
- Medpace
- Medscape Oncology
- Menarini Stemline
- Merck
- MERIT
- MJH Life Sciences
- Moderna
- Moffitt Cancer Center
- Mount Carmel Health System
- Multinational Association of Supportive Care in Cancer
- Myriad Genetics
- Natera
- National Cancer Institute
- National Comprehensive Cancer Network
- NCODA
- NeoGenomics
- Noah AI
- Northwell Health
- Northwestern Medicine Lurie Cancer Center
- Novartis
- Novocure
- Nuvation Bio
- Ochsner MD Anderson Cancer Center
- Octozi
- Ohio State University Comprehensive Cancer Center
- Olema Oncology
- Onc.AI
- Oncentric
- ONCOassist
- OncoHost
- OncoLens
- OneMedNet
- OpenEvidence
- Optimapharm
- Opus Regulatory
- OSF HealthCare
- Parabilis Medicines
- Paradigm Health
- Parexel
- Patient Advocate Foundation
- Paxman
- Penn Medicine
- Personalis
- Pfizer
- PharmaMar
- Phesi
- Pierre Fabre
- Portamedic
- Precision for Medicine
- Predicine
- Premier Research
- PSI CRO
- Puma Biotechnology
- QPS
- QuantHealth
- Quest Diagnostics
- Quibim
- Qure.ai
- radiomics.bio
- RadMD
- Rakuten Medical
- RayzeBio
- Regeneron
- Replimune
- Research To Practice
- ResearchDx
- Resonant Clinical Solutions
- Revolution Medicines
- Rigel Pharmaceuticals
- Roswell Park Comprehensive Cancer Center
- RUSH MD Anderson Cancer Center
- Rutgers Cancer Institute
- San Antonio Breast Cancer Symposium
- Sanofi
- Sarah Cannon Research Institute
- Scientist.com
- Sermo
- Servier
- Shengsheng International
- Siemens Healthineers
- Society for Immunotherapy of Cancer
- SOPHiA GENETICS
- Springer Nature
- Sumitomo Pharma America
- Summit Therapeutics
- Syncromune
- Syndax Pharmaceuticals
- Syneos Health
- Taiho Oncology
- Takeda
- TD2 Oncology
- Telix Pharmaceuticals
- Tempus
- TerSera Therapeutics
- The ASCO Post
- The Oncology Institute
- Theradex
- Thermo Fisher Scientific
- Tigermed
- Tolmar
- Trial Library
- TRIO
- TRIO-US
- Truveta
- UCI Health
- Udderly Smooth
- UF Health Cancer Institute
- UI Pharmaceuticals
- University of Miami Sylvester Comprehensive Cancer Center
- UT MD Anderson Cancer Center
- VA National Oncology Program
- Vaniam Group
- Varifarma
- VCU Massey Comprehensive Cancer Center
- Veracyte
- Versiti Clinical Trials
- Visual Science
- Voiant
- Vysioneer
- Waiv
- Wellness House
- Winship Cancer Institute of Emory University
- Wolters Kluwer
- Worldwide Clinical Trials
- WVU Medicine
- Xencor
- Yunu
- Zetagen Therapeutics
Not affiliated with the American Society of Clinical Oncology. Organization details are derived from ASCO’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction